TNFRSF4 and neoplasm: Shibahara et al. demonstrated that the OX40/OX40L (TNFRSF4/ TNFSF4) signaling pathway induced anti-tumor immunity in a mouse glioma model, and OX40 could also trigger regulatory T cells to cause immunosuppression under hypoxia [19].